Tubidy
    Novartis CEO: Our leukemia drug Scemblix is a potential $3 billion plus medicine

    Novartis CEO: Our leukemia drug Scemblix is a potential $3 billion plus medicine

    04:43 |
    Download MP3

    Related Videos

    For Nvidia to continue to work there will be other big winners, says Ark Invest's Cathie Wood 6:29

    For Nvidia to continue to work there will be other big winners, says Ark Invest's Cathie Wood

    U.S. job creation totaled 254,000 in September, much better than expected 3:09

    U.S. job creation totaled 254,000 in September, much better than expected

    Cramer weighs in on whether the Fed has pulled off a soft landing 2:28

    Cramer weighs in on whether the Fed has pulled off a soft landing

    Beijing is trying to put a 'floor' on the economy with its stimulus measures: China Beige Book CEO 7:46

    Beijing is trying to put a 'floor' on the economy with its stimulus measures: China Beige Book CEO

    Billionaire investor Mark Cuban: Our place in the world depends on our ability to invest in AI 7:16

    Billionaire investor Mark Cuban: Our place in the world depends on our ability to invest in AI

    Mad Money - 10/04/24 | Audio Only 44:25

    Mad Money - 10/04/24 | Audio Only

    Lightning Round: Shopify is at a great level to buy, says Jim Cramer 4:56

    Lightning Round: Shopify is at a great level to buy, says Jim Cramer

    Evercore's Roger Altman: Hard for equities to move up materially because they're already so high 5:25

    Evercore's Roger Altman: Hard for equities to move up materially because they're already so high

    Nvidia and Accenture partnership is 'watershed' moment, says Wedbush's Dan Ives 5:49

    Nvidia and Accenture partnership is 'watershed' moment, says Wedbush's Dan Ives

    Nvidia partners with Accenture to encourage adoption of AI 3:47

    Nvidia partners with Accenture to encourage adoption of AI

    The U.S. is enjoying a 'Goldilocks' moment, says BofA's Savita Subramanian 7:29

    The U.S. is enjoying a 'Goldilocks' moment, says BofA's Savita Subramanian

    Fed's rate cut may spark a 'melt-up,' says president of Yardeni Research 3:00

    Fed's rate cut may spark a 'melt-up,' says president of Yardeni Research

    This was the best news I've heard from the Fed in years, says Wharton's Jeremy Siegel 6:48

    This was the best news I've heard from the Fed in years, says Wharton's Jeremy Siegel

    The tech rally will have to wait until year-end, says DataTrek's Nick Colas 4:27

    The tech rally will have to wait until year-end, says DataTrek's Nick Colas

    Google launches new ad interface for AI searches 4:20

    Google launches new ad interface for AI searches

    Fundstrat's Tom Lee on 6,000 S&P 500 year-end target: Setup into year-end has a lot of tailwinds 6:00

    Fundstrat's Tom Lee on 6,000 S&P 500 year-end target: Setup into year-end has a lot of tailwinds

    We should see a 'muted counter-strike' by Israel, says Retired U.S. Army Col. Jack Jacobs 5:05

    We should see a 'muted counter-strike' by Israel, says Retired U.S. Army Col. Jack Jacobs

    Fast Money traders share their favorite stocks of the week 3:27

    Fast Money traders share their favorite stocks of the week

    Billionaire investor Leon Cooperman on his favorite holdings 8:01

    Billionaire investor Leon Cooperman on his favorite holdings

    We are more skewed to the positive now, says Trivariate's Adam Parker 3:42

    We are more skewed to the positive now, says Trivariate's Adam Parker